{"id":"https://openalex.org/W4390952814","doi":"https://doi.org/10.1186/s13075-023-03232-2","title":"Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study","display_name":"Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study","publication_year":2024,"publication_date":"2024-01-17","ids":{"openalex":"https://openalex.org/W4390952814","doi":"https://doi.org/10.1186/s13075-023-03232-2","pmid":"https://pubmed.ncbi.nlm.nih.gov/38233885","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10792872"},"language":"en","primary_location":{"id":"doi:10.1186/s13075-023-03232-2","doi":"https://doi.org/10.1186/s13075-023-03232-2","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13075-023-03232-2","pdf_url":"https://arthritis-research.biomedcentral.com/counter/pdf/10.1186/s13075-023-03232-2","source":{"id":"https://openalex.org/S149170128","display_name":"Arthritis Research & Therapy","issn_l":"1478-6354","issn":["1478-6354","1478-6362"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis Research & Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://arthritis-research.biomedcentral.com/counter/pdf/10.1186/s13075-023-03232-2","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021312163","display_name":"Rohit Aggarwal","orcid":"https://orcid.org/0000-0001-7531-8038","observed_orcids":["https://orcid.org/0000-0001-7531-8038","https://orcid.org/0000-0002-4508-1233"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Rohit Aggarwal","raw_affiliation_strings":["Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. aggarwalr@upmc.edu","Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. aggarwalr@upmc.edu","institution_ids":["https://openalex.org/I170201317"]},{"raw_affiliation_string":"Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005374186","display_name":"Joachim Schessl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Joachim Schessl","raw_affiliation_strings":["Department of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians University of Munich, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians University of Munich, Munich, Germany","institution_ids":["https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027269428","display_name":"Christina Charles\u2010Schoeman","orcid":"https://orcid.org/0000-0002-1768-7019","observed_orcids":["https://orcid.org/0000-0002-1768-7019"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christina Charles-Schoeman","raw_affiliation_strings":["University of California, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070831366","display_name":"Zsuzsanna Bata\u2010Cs\u00f6rg\u00f5","orcid":"https://orcid.org/0000-0002-3732-1743","observed_orcids":["https://orcid.org/0000-0002-3732-1743"]},"institutions":[{"id":"https://openalex.org/I227486990","display_name":"University of Szeged","ror":"https://ror.org/01pnej532","country_code":"HU","type":"education","lineage":["https://openalex.org/I227486990"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"Zsuzsanna Bata-Cs\u00f6rg\u0151","raw_affiliation_strings":["Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary","institution_ids":["https://openalex.org/I227486990"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051045476","display_name":"Mazen M. Dimachkie","orcid":"https://orcid.org/0000-0002-7148-989X","observed_orcids":["https://orcid.org/0000-0002-7148-989X"]},"institutions":[{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mazen M. Dimachkie","raw_affiliation_strings":["Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA","institution_ids":["https://openalex.org/I4210128618"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056706307","display_name":"Zolt\u00e1n Griger","orcid":"https://orcid.org/0000-0002-1371-7911","observed_orcids":["https://orcid.org/0000-0002-1371-7911"]},"institutions":[{"id":"https://openalex.org/I132735039","display_name":"University of Debrecen","ror":"https://ror.org/02xf66n48","country_code":"HU","type":"education","lineage":["https://openalex.org/I132735039"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"Zoltan Griger","raw_affiliation_strings":["Division of Clinical Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary","institution_ids":["https://openalex.org/I132735039"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110842346","display_name":"Sergey Moiseev","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I17877952","display_name":"Sechenov University","ror":"https://ror.org/02yqqv993","country_code":"RU","type":"education","lineage":["https://openalex.org/I17877952"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Sergey Moiseev","raw_affiliation_strings":["Tareev Clinic of Internal Diseases, Sechenov First Moscow State Medical University, Moscow, Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tareev Clinic of Internal Diseases, Sechenov First Moscow State Medical University, Moscow, Russia","institution_ids":["https://openalex.org/I17877952"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072041025","display_name":"Chester V. Oddis","orcid":"https://orcid.org/0000-0002-9529-3111","observed_orcids":["https://orcid.org/0000-0002-9529-3111"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chester V. Oddis","raw_affiliation_strings":["Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000524323","display_name":"Elena Schiopu","orcid":"https://orcid.org/0000-0002-1831-5292","observed_orcids":["https://orcid.org/0000-0002-1831-5292"]},"institutions":[{"id":"https://openalex.org/I25041050","display_name":"Augusta University","ror":"https://ror.org/012mef835","country_code":"US","type":"education","lineage":["https://openalex.org/I25041050"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elena Schiopu","raw_affiliation_strings":["Division of Rheumatology, Medical College of Georgia at Augusta University, Augusta, GA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Rheumatology, Medical College of Georgia at Augusta University, Augusta, GA, USA","institution_ids":["https://openalex.org/I25041050"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079921904","display_name":"Ji\u0159\u00ed Vencovsk\u00fd","orcid":"https://orcid.org/0000-0002-0851-0713","observed_orcids":["https://orcid.org/0000-0002-0851-0713"]},"institutions":[{"id":"https://openalex.org/I21250087","display_name":"Charles University","ror":"https://ror.org/024d6js02","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21250087"]},{"id":"https://openalex.org/I4210092695","display_name":"Institute of Rheumatology","ror":"https://ror.org/00jk0vn85","country_code":"CZ","type":"facility","lineage":["https://openalex.org/I4210092695"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"Jiri Vencovsk\u00fd","raw_affiliation_strings":["Institute of Rheumatology and Department of Rheumatology, 1st Medical Faculty, Charles University, Prague, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Rheumatology and Department of Rheumatology, 1st Medical Faculty, Charles University, Prague, Czech Republic","institution_ids":["https://openalex.org/I21250087","https://openalex.org/I4210092695"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015276099","display_name":"Irene K. Beckmann","orcid":"https://orcid.org/0000-0003-0929-9494","observed_orcids":["https://orcid.org/0000-0003-0929-9494"]},"institutions":[{"id":"https://openalex.org/I4210111127","display_name":"Octapharma (Austria)","ror":"https://ror.org/022k50n33","country_code":"AT","type":"company","lineage":["https://openalex.org/I4210087655","https://openalex.org/I4210111127"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Irene Beckmann","raw_affiliation_strings":["Octapharma Pharmazeutika Produktionsges. m.b.H., Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Octapharma Pharmazeutika Produktionsges. m.b.H., Vienna, Austria","institution_ids":["https://openalex.org/I4210111127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044710211","display_name":"Elisabeth Clodi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111127","display_name":"Octapharma (Austria)","ror":"https://ror.org/022k50n33","country_code":"AT","type":"company","lineage":["https://openalex.org/I4210087655","https://openalex.org/I4210111127"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Elisabeth Clodi","raw_affiliation_strings":["Octapharma Pharmazeutika Produktionsges. m.b.H., Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Octapharma Pharmazeutika Produktionsges. m.b.H., Vienna, Austria","institution_ids":["https://openalex.org/I4210111127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112266809","display_name":"Todd Levine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140312","display_name":"Phoenix Neurological Associates","ror":"https://ror.org/04hk0mm26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210140312"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Todd Levine","raw_affiliation_strings":["Phoenix Neurological Associates, Ltd, Phoenix, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phoenix Neurological Associates, Ltd, Phoenix, AZ, USA","institution_ids":["https://openalex.org/I4210140312"]}]},{"author_position":"last","author":{"id":null,"display_name":"the ProDERM investigators","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"the ProDERM investigators","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":12,"corresponding_author_ids":["https://openalex.org/A5021312163"],"corresponding_institution_ids":["https://openalex.org/I170201317"],"apc_list":{"value":3390,"currency":"USD","value_usd":3390},"apc_paid":{"value":3390,"currency":"USD","value_usd":3390},"fwci":7.2753,"has_fulltext":true,"cited_by_count":25,"citation_normalized_percentile":{"value":0.97961258,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"26","issue":"1","first_page":"27","last_page":"27"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11724","display_name":"Inflammatory Myopathies and Dermatomyositis","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11724","display_name":"Inflammatory Myopathies and Dermatomyositis","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11271","display_name":"Myasthenia Gravis and Thymoma","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dermatomyositis","display_name":"dermatomyositis","score":0.8889999985694885},{"id":"https://openalex.org/keywords/intravenous-immunoglobulin","display_name":"intravenous immunoglobulin","score":1.0},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.6859999895095825},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.9089999794960022},{"id":"https://openalex.org/keywords/thromboembolic-events","display_name":"thromboembolic events","score":0.9739999771118164},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.8640000224113464},{"id":"https://openalex.org/keywords/infusion-rate","display_name":"infusion rate","score":0.6800000071525574},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.6079999804496765},{"id":"https://openalex.org/keywords/idiopathic-inflammatory-myopathies","display_name":"idiopathic inflammatory myopathies","score":0.8420000076293945},{"id":"https://openalex.org/keywords/adult-patients","display_name":"adult patients","score":0.49300000071525574},{"id":"https://openalex.org/keywords/hemolytic-transfusion-reaction","display_name":"hemolytic transfusion reaction","score":0.8119999766349792},{"id":"https://openalex.org/keywords/drug-related-adverse-events","display_name":"drug-related adverse events","score":0.3490000069141388},{"id":"https://openalex.org/keywords/open-label-extension","display_name":"open-label extension","score":0.4449999928474426},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.36899998784065247}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9509263038635254},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8602891564369202},{"id":"https://openalex.org/C2778751314","wikidata":"https://www.wikidata.org/wiki/Q681160","display_name":"Dermatomyositis","level":2,"score":0.8529778122901917},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7699727416038513},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.7230607271194458},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4856959283351898},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4277706742286682},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.417360782623291},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3518882989883423},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003882","descriptor_name":"Dermatomyositis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009220","descriptor_name":"Myositis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D016756","descriptor_name":"Immunoglobulins, Intravenous","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1186/s13075-023-03232-2","doi":"https://doi.org/10.1186/s13075-023-03232-2","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13075-023-03232-2","pdf_url":"https://arthritis-research.biomedcentral.com/counter/pdf/10.1186/s13075-023-03232-2","source":{"id":"https://openalex.org/S149170128","display_name":"Arthritis Research & Therapy","issn_l":"1478-6354","issn":["1478-6354","1478-6362"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis Research & Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10792872","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10792872","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10792872/pdf/13075_2023_Article_3232.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis Res Ther","raw_type":"Text"},{"id":"pmid:38233885","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38233885","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis research & therapy","raw_type":"Randomized Controlled Trial"},{"id":"pmh:oai:frl.publisso.de:frl:6501204","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10792872","pdf_url":null,"source":{"id":"https://openalex.org/S4377196269","display_name":"PUBLISSO (German National Library of Medicine)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210112663","host_organization_name":"ZB MED - Information Centre for Life Sciences","host_organization_lineage":["https://openalex.org/I4210112663"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Arthritis research, 26(1):27","raw_type":"Zeitschriftenartikel"},{"id":"pmh:oai:doaj.org/article:c02e04d1eff84292a11f1bc97c530c10","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/c02e04d1eff84292a11f1bc97c530c10","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Arthritis Research & Therapy, Vol 26, Iss 1, Pp 1-13 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s13075-023-03232-2","doi":"https://doi.org/10.1186/s13075-023-03232-2","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13075-023-03232-2","pdf_url":"https://arthritis-research.biomedcentral.com/counter/pdf/10.1186/s13075-023-03232-2","source":{"id":"https://openalex.org/S149170128","display_name":"Arthritis Research & Therapy","issn_l":"1478-6354","issn":["1478-6354","1478-6362"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis Research & Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320310420","display_name":"CSL Behring","ror":"https://ror.org/01jxhxv92"},{"id":"https://openalex.org/F4320315434","display_name":"Sarepta Therapeutics","ror":"https://ror.org/054f2wp19"},{"id":"https://openalex.org/F4320315766","display_name":"Myositis Association","ror":"https://ror.org/03ha87v47"},{"id":"https://openalex.org/F4320318412","display_name":"Argenx","ror":"https://ror.org/04spfxf63"},{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"},{"id":"https://openalex.org/F4320331566","display_name":"Roivant Sciences","ror":"https://ror.org/02ac08586"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"},{"id":"https://openalex.org/F4320333587","display_name":"Sanofi Genzyme","ror":null},{"id":"https://openalex.org/F4320334149","display_name":"Spark Therapeutics","ror":"https://ror.org/00s93j442"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4390952814.pdf","grobid_xml":"https://content.openalex.org/works/W4390952814.grobid-xml"},"referenced_works_count":35,"referenced_works":["https://openalex.org/W184510336","https://openalex.org/W1720722670","https://openalex.org/W1903202103","https://openalex.org/W1992854450","https://openalex.org/W2036506588","https://openalex.org/W2056820060","https://openalex.org/W2062062486","https://openalex.org/W2072005725","https://openalex.org/W2075073120","https://openalex.org/W2076417190","https://openalex.org/W2134864031","https://openalex.org/W2137565253","https://openalex.org/W2143178246","https://openalex.org/W2144703918","https://openalex.org/W2159985097","https://openalex.org/W2167728254","https://openalex.org/W2169470682","https://openalex.org/W2272245864","https://openalex.org/W2314311014","https://openalex.org/W2315610003","https://openalex.org/W2530120087","https://openalex.org/W2753467806","https://openalex.org/W2763851112","https://openalex.org/W2791394726","https://openalex.org/W2793931640","https://openalex.org/W2804781394","https://openalex.org/W2969943308","https://openalex.org/W2994281562","https://openalex.org/W3093829239","https://openalex.org/W3120695991","https://openalex.org/W3149772139","https://openalex.org/W3201477350","https://openalex.org/W4281634596","https://openalex.org/W4302023865","https://openalex.org/W4376118447"],"related_works":["https://openalex.org/W6921116608","https://openalex.org/W4389366689","https://openalex.org/W4295259555","https://openalex.org/W4387251773","https://openalex.org/W3120695991","https://openalex.org/W4412043928","https://openalex.org/W3164182876","https://openalex.org/W4302023865","https://openalex.org/W4413476804","https://openalex.org/W4411430954"],"abstract_inverted_index":{"BACKGROUND:":[0],"Dermatomyositis":[1,287],"is":[2,21],"an":[3],"idiopathic":[4],"inflammatory":[5],"myopathy":[6],"characterised":[7],"by":[8],"rashes":[9],"and":[10,32,53,181,240,274,297],"progressive":[11],"muscle":[12],"weakness.":[13],"The":[14,129],"recent":[15],"ProDERM":[16,61,64,319],"(Progress":[17],"in":[18,38,57,146,175,183,202,208,311],"DERMatomyositis)":[19],"study":[20,259,320],"the":[22,30,51,60,75,98,147,165,236,244],"first":[23,76,148,166],"large":[24],"randomised,":[25,68],"placebo-controlled":[26],"trial":[27],"to":[28,48,135,155,173,194,215,280,306],"establish":[29],"efficacy":[31],"safety":[33,52,266],"of":[34,44,55,238,270,301],"intravenous":[35],"immunoglobulin":[36],"(IVIg)":[37],"adult":[39,271],"patients":[40,58,105,119,131,177,185,190,204,210,273,288],"with":[41,81,150,218,313],"dermatomyositis.":[42],"Objectives":[43],"this":[45,258],"analysis":[46],"were":[47,120,126,133,162,170,211],"closely":[49],"examine":[50],"tolerability":[54],"IVIg":[56,87,107,137,159,180,246,262,291],"from":[59,153,257],"study.":[62,73],"METHODS:":[63],"was":[65,116],"a":[66,264,298],"double-blind,":[67],"placebo-controlled,":[69],"multicentre,":[70],"phase":[71],"3":[72],"In":[74,97],"period":[77,101],"(weeks":[78,102],"0-16),":[79],"adults":[80],"active":[82],"dermatomyositis":[83,272],"received":[84,106],"2.0":[85],"g/kg":[86],"(Octagam":[88],"10%;":[89],"Octapharma":[90],"AG)":[91],"or":[92,141,252],"placebo":[93,142,154],"every":[94],"4":[95],"weeks.":[96],"open-label":[99],"extension":[100],"16-40),":[103],"all":[104],"for":[108,268,284,295],"6":[109],"additional":[110],"cycles;":[111],"dose":[112],"reduction":[113],"(1.0":[114],"g/kg)":[115],"permitted":[117],"if":[118],"stable.":[121],"Treatment-emergent":[122],"adverse":[123],"events":[124,199],"(TEAEs)":[125],"documented.":[127],"RESULTS:":[128],"95":[130],"enrolled":[132],"randomised":[134],"receive":[136],"(N":[138,143],"=":[139,144],"47)":[140],"48)":[145],"period,":[149,167],"5":[151],"switching":[152],"IVIg.":[156,216],"Overall,":[157],"664":[158],"infusion":[160,233,302],"cycles":[161],"administered.":[163],"During":[164],"113":[168],"TEAEs":[169],"possibly/probably":[171,213],"related":[172,214],"treatment":[174,269,282],"30/52":[176],"(57.7%)":[178],"receiving":[179,289],"38":[182],"11":[184],"(22.9%)":[186],"on":[187,205],"placebo.":[188],"Eight":[189,197],"discontinued":[191],"therapy":[192],"due":[193],"IVIg-related":[195],"TEAEs.":[196],"thromboembolic":[198],"(TEEs)":[200],"occurred":[201,242],"six":[203,207],"IVIg;":[206],"five":[209],"deemed":[212],"Patients":[217],"TEEs":[219,229],"exhibited":[220],"more":[221],"baseline":[222],"TEE":[223,308],"risk":[224,315],"factors":[225],"than":[226],"those":[227,312],"without":[228],"(2.4-15.2-fold":[230],"higher).":[231],"Lowering":[232],"rate":[234,237,300],"reduced":[235],"TEEs,":[239,296],"none":[241],"at":[243],"lower":[245],"dose.":[247],"No":[248],"haemolytic":[249],"transfusion":[250],"reactions":[251],"deaths":[253],"occurred.":[254],"CONCLUSIONS:":[255],"Results":[256],"demonstrate":[260],"that":[261,277],"has":[263],"favourable":[265],"profile":[267],"provides":[275],"evidence":[276],"will":[278],"help":[279],"inform":[281],"choice":[283],"these":[285],"patients.":[286],"high-dose":[290],"should":[292,303],"be":[293,304],"monitored":[294],"low":[299],"used":[305],"minimise":[307],"risk,":[309],"particularly":[310],"pre-existing":[314],"factors.":[316],"TRIAL":[317],"REGISTRATION:":[318],"(NCT02728752).":[321]},"counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":7}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2024-01-18T00:00:00"}